🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 hora
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/09/2022 | 0,6900 USD |
| 14/06/2022 | 0,6900 USD |
| 14/03/2022 | 0,6900 USD |
| 14/12/2021 | 0,6900 USD |
| 14/09/2021 | 0,6500 USD |
| 14/06/2021 | 0,6500 USD |
| 12/03/2021 | 0,6202 USD |
| 14/12/2020 | 0,6202 USD |
| 14/09/2020 | 0,5821 USD |
| 12/06/2020 | 0,5821 USD |
| 13/03/2020 | 0,5821 USD |
| 13/12/2019 | 0,5821 USD |
| 13/09/2019 | 0,5248 USD |
| 14/06/2019 | 0,5248 USD |
| 14/03/2019 | 0,5248 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 02/09/2003 | 47,85 | 48,89 | 47,85 | 48,73 | +1,49% | 2,17% | 7.970.669 |
| 29/08/2003 | 47,66 | 48,06 | 47,52 | 48,02 | +1,13% | 1,14% | 5.379.908 |
| 28/08/2003 | 48,01 | 48,06 | 47,21 | 47,48 | -1,07% | 1,77% | 7.064.778 |
| 27/08/2003 | 47,76 | 48,11 | 47,76 | 48,00 | +0,00% | 0,74% | 5.460.918 |
| 26/08/2003 | 48,01 | 48,18 | 47,60 | 48,00 | +0,02% | 1,21% | 6.972.763 |
| 25/08/2003 | 47,85 | 48,60 | 47,85 | 47,99 | +0,04% | 1,56% | 5.970.875 |
| 22/08/2003 | 49,05 | 49,10 | 47,85 | 47,97 | -2,05% | 2,55% | 9.283.394 |
| 21/08/2003 | 49,90 | 49,90 | 48,76 | 48,97 | -1,53% | 2,29% | 8.971.194 |
| 20/08/2003 | 48,58 | 50,01 | 48,57 | 49,73 | -2,98% | 2,97% | 10.712.551 |
| 19/08/2003 | 51,05 | 51,48 | 50,38 | 51,26 | +0,43% | 2,15% | 6.107.639 |
| 18/08/2003 | 51,10 | 51,36 | 50,95 | 51,04 | +0,02% | 0,78% | 5.235.179 |
| 15/08/2003 | 50,91 | 51,14 | 50,24 | 51,03 | +0,26% | 1,76% | 3.705.309 |
| 14/08/2003 | 50,68 | 50,95 | 50,12 | 50,90 | -0,15% | 1,64% | 6.903.490 |
| 13/08/2003 | 51,57 | 51,77 | 50,67 | 50,97 | -2,04% | 2,13% | 7.904.750 |
| 12/08/2003 | 52,50 | 52,58 | 51,60 | 52,03 | -0,93% | 1,85% | 6.142.328 |
| 11/08/2003 | 53,05 | 53,12 | 51,97 | 52,52 | -0,99% | 2,18% | 6.192.108 |
| 08/08/2003 | 53,34 | 53,44 | 52,81 | 53,04 | -0,55% | 1,20% | 4.786.426 |
| 07/08/2003 | 51,91 | 53,48 | 51,77 | 53,34 | +3,10% | 3,29% | 8.407.266 |
| 06/08/2003 | 51,06 | 52,22 | 50,76 | 51,74 | +1,33% | 2,86% | 5.992.778 |
| 05/08/2003 | 51,72 | 52,28 | 50,95 | 51,06 | -1,15% | 2,56% | 7.614.034 |
| 04/08/2003 | 51,62 | 51,86 | 50,81 | 51,65 | -0,17% | 2,03% | 6.805.188 |
| 01/08/2003 | 52,49 | 52,57 | 51,05 | 51,74 | -1,92% | 2,89% | 7.591.607 |
| 31/07/2003 | 53,29 | 54,01 | 52,51 | 52,75 | -0,32% | 2,81% | 7.254.885 |
| 30/07/2003 | 53,02 | 53,63 | 52,64 | 52,92 | +0,13% | 1,85% | 6.722.396 |
| 29/07/2003 | 54,37 | 54,49 | 52,58 | 52,85 | -2,24% | 3,53% | 13.749.865 |
| 28/07/2003 | 54,85 | 54,87 | 53,67 | 54,06 | -1,50% | 2,17% | 6.385.254 |
| 25/07/2003 | 54,06 | 54,89 | 53,66 | 54,89 | +0,93% | 2,26% | 5.776.157 |
| 24/07/2003 | 55,53 | 55,56 | 54,28 | 54,38 | -1,55% | 2,30% | 6.182.886 |
| 23/07/2003 | 54,87 | 55,49 | 54,48 | 55,24 | +0,14% | 1,83% | 6.371.945 |
| 22/07/2003 | 56,77 | 56,87 | 54,63 | 55,16 | -3,36% | 3,95% | 12.449.821 |